Company news
IceCure Medical Ltd. news in 2023
IceCure Medical Ltd.'s news releases, calls and decks from 2023, newest first.
IceCure's ProSense® Deepens Regulatory Approval in India
November 28, 2023
IceCure System Successfully Treated Kidney Cancer Tumor with 92% Disease-Free Survival Rate and 100% Secondary Local Control Rate
November 27, 2023
IceCure Medical Reports Financial Results as of and for the Nine Months Ended September 30, 2023, and Provides Update on Recent Operational Highlights
November 14, 2023
IceCure Medical Files Appeal with U.S. FDA Requesting a Review of its De Novo Classification for ProSense® in Early-Stage Breast Cancer
November 14, 2023
Women Deemed Inoperable for Breast Cancer Benefitted from IceCure Medical's ProSense as an Independent Study Performed in Italy Showed a Tumor Reduction Rate of 93.43% to 96.81%
October 4, 2023
Independent Study Validates IceCure's ProSense Cryoablation is Safe & Effective Outpatient Procedure for Breast Cancer with 96.8% Success Rate
October 1, 2023
IceCure Medical Receives FDA Response to De Novo Classification Request for Breast Cancer
September 19, 2023
IceCure Medical's ProSense Cryoablation System Receives Regulatory Approval in Brazil
September 4, 2023
IceCure Medical Takes Next Major Initiative as it Prepares to Accelerate the Commercialization of ProSense in U.S. and Canada: Appoints VP of Sales, North America
August 27, 2023
IceCure Medical Reports First Half 2023 Financial & Operational Results: Global Adoption of Cryoablation Technology Gaining Momentum
August 13, 2023
IceCure Medical to Report Second Quarter 2023 Financial & Operational Results on August 14, 2023
August 6, 2023
Health Canada Approves IceCure Medical's Minimally Invasive ProSense Cryoablation System
July 23, 2023
IceCure Medical Expands Distribution of ProSense® into Portugal Through Agreement with Medicinália Cormédica: Upfront Systems & Probes Sales
July 16, 2023
IceCure's ProSense Installation in India is the First to Offer Cryoablation for the Treatment of Breast Cancer in the Country
May 30, 2023
IceCure Medical Reports First Quarter 2023 Financial & Operational Results
May 21, 2023
IceCure Medical Ordinary Shares to Trade Exclusively on Nasdaq: Company to Voluntarily Delist Shares from Trading on the Tel Aviv Stock Exchange
April 18, 2023
IceCure Medical Receives Regulatory Approval in China for Commercial Use of its IceSense3 Disposable Cryoprobes
March 27, 2023
IceCure Medical Announces Preliminary Unaudited 2022 Year-End Financial Results & Recent Operational Highlights
February 8, 2023
IceCure Receives Notice of Patent Allowance in Japan for a Novel Cryogenic Pump for its Next-Generation Cryoablation Systems
January 17, 2023